"L'hôpital Lyon-Sud dispose de services d’excellence, notamment dans les domaines de la cancérologie, de l’hématologie, de la nutrition, de la dermatologie ainsi que dans de multiples spécialités chirurgicales comme l’orthopédie et la chirurgie digestive. C’est un établissement de référence dans la prise en charge des urgences, des femmes enceintes et des patients âgés."

During the past decade, Centre Hospitalier Lyon Sud; Dermatologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Lyon Sud; Dermatologie" are "Basal Cell Carcinoma" (2 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Centre Hospitalier Lyon Sud; Dermatologie" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Lyon Sud; Dermatologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lebrikizumab" (1 trials), "Placebo" (1 trials), "TCS Cream" (1 trials) and "vismodegib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Lyon Sud; Dermatologie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Centre Hospitalier Lyon Sud; Dermatologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centre Hospitalier Lyon Sud; Dermatologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Lyon Sud; Dermatologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".